These results indicate CAF-derived CXCL16 as a critical regulator of TNFR2+ Treg accumulation and MPE progression, with conserved tumor-type effects suggesting suggesting broader implications in malignant progression. The gene discussed is TNFRSF1B; the disease is neoplasm.